{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464379187
| IUPAC_name = 2-(4-methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone
| image = RCS-4 molecular structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Schedule I
| legal_DE = Anlage II
| legal_status = Illegal in Sweden, I-N (Poland)<ref>{{cite web | title = Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 ) | url = http://isap.sejm.gov.pl/DetailsServlet?id=WDU20111050614 | publisher = Internetowy System Aktów Prawnych | accessdate = 12 June 2011}}</ref>

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 1345966-78-0
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 24769418

<!--Chemical data-->
| C=21 | H=23 | N=1 | O=2 
| molecular_weight = 321.413 g/mol
| smiles = CCCCCn1cc(c2c1cccc2)C(=O)c3ccc(cc3)OC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H23NO2/c1-3-4-7-14-22-15-19(18-8-5-6-9-20(18)22)21(23)16-10-12-17(24-2)13-11-16/h5-6,8-13,15H,3-4,7,14H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = OZCYJKDWRUIFFE-UHFFFAOYSA-N
}}

'''RCS-4''', or '''1-pentyl-3-(4-methoxybenzoyl)indole''', is a [[synthetic cannabinoid]] drug sold under the names '''SR-19''', '''BTM-4''', or '''Eric-4''' (later shortened to '''E-4'''), but originally, '''OBT-199'''.

==Pharmacology==
RCS-4 is a potent cannabinoid receptor agonist, with  EC<sub>50</sub> values of 146 nM for human CB<sub>1</sub> receptors, and 46 nM for human CB<sub>2</sub> receptors.<ref name = "Forensic Toxicol 2015">{{Cite journal | doi = 10.1007/s11419-015-0282-9| title = Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues| journal = Forensic Toxicology| volume = 33| issue = 2| pages = 355| year = 2015| last1 = Banister | first1 = S. D. | last2 = Stuart | first2 = J. | last3 = Conroy | first3 = T. | last4 = Longworth | first4 = M. | last5 = Manohar | first5 = M. | last6 = Beinat | first6 = C. | last7 = Wilkinson | first7 = S. M. | last8 = Kevin | first8 = R. C. | last9 = Hibbs | first9 = D. E. | last10 = Glass | first10 = M. | last11 = Connor | first11 = M. | last12 = McGregor | first12 = I. S. | last13 = Kassiou | first13 = M. }}</ref> All methoxyphenyl regioisomers, and ''N''-butyl homologues of RCS-4 and its regioisomers also display potent agonist activities at CB<sub>1</sub> and CB<sub>2</sub> receptors.<ref name = "Forensic Toxicol 2015" />

==Legality==
RCS-4 was banned in Sweden on 1 October 2010 as a hazardous good harmful to health, after being identified as an ingredient in "herbal" [[synthetic cannabis]] products.<ref>[http://www.riksdagen.se/webbnav/index.aspx?nid=3911&bet=1999:58 Swedish Code of Statutes Regulation (2010:1086).]</ref><ref>[http://www.lagboken.se/files/SFS/2010/101086.PDF Swedish Code of Statutes Regulation (2010:1086). (pdf)]</ref>

It was outlawed in Denmark on 11 March 2011.<ref>http://laegemiddelstyrelsen.dk/~/media/AC4F04EB48F74523A76BA84DAB9B6067.ashx</ref> 

In August 2011, New Zealand added not only RCS-4 but also its 1-butyl homologue, and the 2-methoxybenzoyl isomers of both these compounds, to a temporary class drug schedule (i.e. equivalent to Class C but reviewed after 12 months, and with personal possession and use of small amounts decriminalised), which was newly created under the Misuse of Drugs Amendment Act 2011 passed a week earlier.<ref name="NZ_Herald_10742964">{{cite news |url=http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10742964 |title=Kronic ban passed by Parliament |date=4 August 2011 |agency=[[NZPA]] |work=[[The New Zealand Herald]] |accessdate=4 November 2011}}</ref><ref name="NZ_Herald_10743976">{{cite news |url=http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10743976 |title=Synthetic cannabis off shelves by Wednesday |date=9 August 2011 |agency=[[NZPA]] |work=[[The New Zealand Herald]] |accessdate=4 November 2011}}</ref><ref>New Zealand Gazette. Tuesday 9 August 2011. Issue No 122, pp 3365-3366. Departmental Notices. Health. Misuse of Drugs Act 1975. Temporary Class Drug Notice.</ref>

As of October 2015 RCS-4 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

[[Image:RCS4-analogues.png|300px|thumb|none|RCS-4 and related analogues detected in synthetic cannabis blends]]

==See also==
*[[AM-630]]
*[[AM-679 (cannabinoid)|AM-679]]
*[[RCS-8]]
*[[Pravadoline]] (WIN 48,098)
*[[Structural scheduling of synthetic cannabinoids]]

==References==
<references/>

{{cannabinoids}}

[[Category:Benzoylindoles]]
[[Category:Designer drugs]]